Journal
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Volume 16, Issue 2, Pages 161-163Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0924-8579(00)00232-6
Keywords
mucositis; chemotherapy; radiotherapy; thalidomide; melatonin; amifostine
Ask authors/readers for more resources
This review summarises the large number of locally and systemically applied preventive and therapeutic interventions of mucositis in patients with cancer. The need for further elucidation of the pathophysiology and for optimisation of trial methodology is emphasised. Data from trials in animal models and preliminary data in patients indicate that cytokines such as interleukin-1, interleukin-11, TGF-beta3 and keratinocyte growth factor could reduce the incidence of mucositis. Other potentially useful agents are the angiogenesis-inhibiting drug thalidomide, the cytoprotector amifostine and the pineal hormone melatonin. (C) 2000 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available